Everyday Health on MSN
How to afford COPD medications on a fixed income
Managing COPD on a fixed income can be financially straining. Discover options, Medicare Extra Help, and nonprofit resources ...
A large clinical trial testing a once-daily inhaled treatment for PAH is now recruiting, after data showed long-term benefits ...
A 12-week prospective cohort enrolled 73 patients with guideline-based asthma or COPD and no speech-affecting comorbidities, ...
In one phase 3 trial, former smokers with COPD receiving itepekimab had a significantly lower annualized moderate/severe ...
WASHINGTON, D.C. – Today, U.S. Senator Tammy Baldwin (D-WI), a member of the Senate Committee on Health, Education, Labor, and Pensions, celebrated the announcement that AstraZeneca will cap the cost ...
Some people with severe and often rare lung diseases may reach a point where there are no remaining effective treatment options available, and they may not qualify for or have access to a clinical ...
Astrazeneca plc has added a dual PDE3/4 inhibitor candidate to its chronic obstructive pulmonary disease (COPD) portfolio via ...
Perfect gentleman’ who was exposed to asbestos died from multiple factors | Reporting from Preston Coroner’s Court ...
State Rep. Liz Hanbidge plans to introduce legislation that would cap the cost of epinephrine delivery systems and limit ...
AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challenger to Merck & ...
Early identification and treatment of patients with COPD at risk of exacerbation are crucial for better outcomes. Single-inhaler triple therapy (SITT) users showed improved exacerbation rates and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results